Forbion Promotes Mathias Vinther to Partner in Growth Fund
Forbion, a leading European life sciences investment firm, has promoted Mathias Vinther to Partner within its Growth Fund. Effective October 21, 2025, Vinther takes on an expanded leadership role, shaping the fund's strategy and strengthening its network.
Vinther joined Forbion in March 2022 as Principal and has since proven his worth, contributing to several successful exits and IPOs. In his new role, he will make key investment decisions and guide portfolio companies. His expertise in business and regulatory strategy has already benefited companies like Navigator, Vectiv Bio, and Capstan.
Vinther's promotion comes after leading due diligence on numerous growth-stage biotech opportunities across Europe and the US. His ability to identify promising investments and support portfolio companies has made him a valuable addition to Forbion's leadership team.
Mathias Vinther's promotion to Partner reflects his significant contributions to Forbion's Growth Fund. His expanded role will further strengthen the fund's strategy and investment capabilities, as he continues to guide portfolio companies and grow the firm's network.
